![]() |
|
|
K Williams, AM Zappia, DB Pritchett, YM Shen and PB Molinoff
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104-6084.
The endogenous polyamine spermine has multiple effects on the N-methyl- D-aspartate (NMDA) receptor. These include an increase in the magnitude of NMDA-induced whole-cell currents that is seen in the presence of saturating concentrations of glycine ("glycine-independent" stimulation), an increase in the affinity of the receptor for glycine ("glycine-dependent" stimulation), and voltage-dependent inhibition. Although many of the properties of native NMDA receptors are seen with homomeric NR1 receptors expressed in Xenopus oocytes, we have found that the effects of spermine are differentially regulated by NR2 subunits in heteromeric NR1/NR2 receptors. Glycine-independent stimulation by spermine occurred at homomeric NR1A receptors, which lack the amino-terminal insert in NR1, and at heteromeric NR1A/NR2B receptors but not at heteromeric NR1A/NR2A or NR1A/NR2C receptors. Glycine-independent stimulation was not seen at homomeric NR1B receptors, which include the amino-terminal insert in NR1, or at heteromeric receptors containing NR1B. Thus, glycine-independent stimulation by polyamines requires the presence of an NR1 variant, such as NR1A, that lacks the amino-terminal insert, but the manifestation of the stimulatory effect is controlled by the type of NR2 subunit present in a heteromeric complex. Glycine-dependent stimulation was seen at NR1A/NR2A and NR1A/NR2B receptors and may therefore involve a second polyamine binding site distinct from that which produces glycine- independent stimulation. The voltage-dependent inhibitory effect of spermine, which is more pronounced at hyperpolarized membrane potentials, occurred with similar magnitudes at NR1A/NR2A and NR1A/NR2B receptors but was absent at NR1A/NR2C receptors. Thus, NR2 subunits control both the stimulatory and inhibitory effects of spermine at NMDA receptors. Stimulation but not inhibition by spermine was seen at NR1A/NR2B receptors in the presence of extracellular Mg2+. Stimulation, seen in the presence of physiological concentrations of Ca2+ and Mg2+, may be the predominant effect of polyamines at NMDA receptors in the intact nervous system.
This article has been cited by other articles:
![]() |
L. Stoll, J. Hall, N. Van Buren, A. Hall, L. Knight, A. Morgan, S. Zuger, H. Van Deusen, and L. Gentile Differential Regulation of Ionotropic Glutamate Receptors Biophys. J., February 15, 2007; 92(4): 1343 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Erreger, S. M Dravid, T. G Banke, D. J. A Wyllie, and S. F Traynelis Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles J. Physiol., March 1, 2005; 563(2): 345 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kashiwagi, I. Tanaka, M. Tamura, H. Sugiyama, T. Okawara, M. Otsuka, T. N. Sabado, K. Williams, and K. Igarashi Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 884 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Floyd, K.-Y. Jung, and B. A. McCool Chronic Ethanol Ingestion Facilitates N-Methyl-D-aspartate Receptor Function and Expression in Rat Lateral/Basolateral Amygdala Neurons J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1020 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Dunah and D. G. Standaert Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane J. Neurosci., August 1, 2001; 21(15): 5546 - 5558. [Abstract] [Full Text] [PDF] |
||||
![]() |
Th. Els, J. Bruckmann, G. Rohn, M. Daffertshofer, J. S. Monting, R.-I. Ernestus, and M. Hennerici Spermidine: A Predictor for Neurological Outcome and Infarct Size in Focal Cerebral Ischemia? Stroke, January 1, 2001; 32(1): 43 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rumbaugh, K. Prybylowski, J. F. Wang, and S. Vicini Exon 5 and Spermine Regulate Deactivation of NMDA Receptor Subtypes J Neurophysiol, March 1, 2000; 83(3): 1300 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Dunah, Y. Wang, R. P. Yasuda, K. Kameyama, R. L. Huganir, B. B. Wolfe, and D. G. Standaert Alterations in Subunit Expression, Composition, and Phosphorylation of Striatal N-Methyl-D-Aspartate Glutamate Receptors in a Rat 6-Hydroxydopamine Model of Parkinson's Disease Mol. Pharmacol., February 1, 2000; 57(2): 342 - 352. [Abstract] [Full Text] |
||||
![]() |
G. Rumbaugh and S. Vicini Distinct Synaptic and Extrasynaptic NMDA Receptors in Developing Cerebellar Granule Neurons J. Neurosci., December 15, 1999; 19(24): 10603 - 10610. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Martin, S. H. Ahmed, T. Blank, J. Spiess, G. F. Koob, and G. R. Siggins Chronic Morphine Treatment Alters NMDA Receptor-Mediated Synaptic Transmission in the Nucleus Accumbens J. Neurosci., October 15, 1999; 19(20): 9081 - 9089. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Harvey and P. Skolnick Polyamine-Like Actions of Aminoglycosides at Recombinant N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 285 - 291. [Abstract] [Full Text] |
||||
![]() |
T. Masuko, T. Kuno, K. Kashiwagi, T. Kusama, K. Williams, and K. Igarashi Stimulatory and Inhibitory Properties of Aminoglycoside Antibiotics at N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1026 - 1033. [Abstract] [Full Text] |
||||
![]() |
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969. [Abstract] [Full Text] |
||||
![]() |
T. A. Sharma and I. J. Reynolds Characterization of the Effects of Polyamines on [125I]MK-801 Binding to Recombinant N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1041 - 1047. [Abstract] [Full Text] |
||||
![]() |
F. Conti, P. Barbaresi, M. Melone, and A. Ducati Neuronal and Glial Localization of NR1 and NR2A/B Subunits of the NMDA Receptor in the Human Cerebral Cortex Cereb Cortex, March 1, 1999; 9(2): 110 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Danysz and C. G. Parsons Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Traynelis, M. F. Burgess, F. Zheng, P. Lyuboslavsky, and J. L. Powers Control of Voltage-Independent Zinc Inhibition of NMDA Receptors by the NR1 Subunit J. Neurosci., August 15, 1998; 18(16): 6163 - 6175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Brimecombe, M. J. Gallagher, D. R. Lynch, and E. Aizenman An NR2B Point Mutation Affecting Haloperidol and CP101,606 Sensitivity of Single Recombinant N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 627 - 634. [Abstract] [Full Text] |
||||
![]() |
G. Fischer, V. Mutel, G. Trube, P. Malherbe, J. N. C. Kew, E. Mohacsi, M. P. Heitz, and J. A. Kemp Ro 25-6981, a Highly Potent and Selective Blocker of N-Methyl-D-aspartate Receptors Containing the NR2B Subunit. Characterization in Vitro J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1285 - 1292. [Abstract] [Full Text] |
||||
![]() |
M. Park-Chung, F.-S. Wu, R. H. Purdy, A. A. Malayev, T. T. Gibbs, and D. H. Farb Distinct Sites for Inverse Modulation of N-Methyl-D-Aspartate Receptors by Sulfated Steroids Mol. Pharmacol., December 1, 1997; 52(6): 1113 - 1123. [Abstract] [Full Text] |
||||
![]() |
M. J. Gallagher, H. Huang, E. R. Grant, and D. R. Lynch The NR2B-specific Interactions of Polyamines and Protons with the N-Methyl-D-aspartate Receptor J. Biol. Chem., October 3, 1997; 272(40): 24971 - 24979. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Brimecombe, F. A. Boeckman, and E. Aizenman Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors PNAS, September 30, 1997; 94(20): 11019 - 11024. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Paoletti, P. Ascher, and J. Neyton High-Affinity Zinc Inhibition of NMDA NR1-NR2A Receptors J. Neurosci., August 1, 1997; 17(15): 5711 - 5725. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chao, N. Seiler, J. Renault, K. Kashiwagi, T. Masuko, K. Igarashi, and K. Williams N1-Dansyl-Spermine and N1-(n-Octanesulfonyl)-Spermine, Novel Glutamate Receptor Antagonists: Block and Permeation of N-Methyl-D-Aspartate Receptors Mol. Pharmacol., May 1, 1997; 51(5): 861 - 871. [Abstract] [Full Text] |
||||
![]() |
L. L. Coughenour and J. J. Cordon Characterization of Haloperidol and Trifluperidol as Subtype-Selective N-Methyl-D-Aspartate (NMDA) Receptor Antagonists Using [3H]TCP and [3H]Ifenprodil Binding in Rat Brain Membranes J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 584 - 592. [Abstract] [Full Text] |
||||
![]() |
M. J. Gallagher, H. Huang, D. B. Pritchett, and D. R. Lynch Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor J. Biol. Chem., April 19, 1996; 271(16): 9603 - 9611. [Abstract] [Full Text] [PDF] |
||||